Crossref
Optimising Proton Pump Inhibitor Therapy in Cardiovascular Polypharmacy: Expert Opinion and the Role of Rabeprazole
Hypertension Journal · 22.02.2025 · 10 (4) · 94-99
DOI: 10.61081/htnj/24v10i403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension Journal, online erschienen am 22.02.2025. Verfasst von Krishnakumar P und 3 weiteren Autor:innen.
Themen: Medikationssicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
P, K., Mondal, S. C., Rath, H., & Chawla, K. (2025). Optimising Proton Pump Inhibitor Therapy in Cardiovascular Polypharmacy: Expert Opinion and the Role of Rabeprazole. Hypertension Journal, 10(4), 94-99. https://doi.org/10.61081/htnj/24v10i403
Vancouver
P K, Mondal SC, Rath H, Chawla K. Optimising Proton Pump Inhibitor Therapy in Cardiovascular Polypharmacy: Expert Opinion and the Role of Rabeprazole. Hypertension Journal. 2025;10(4):94-99. doi:10.61081/htnj/24v10i403
BibTeX
@article{P2025,
author = {P, Krishnakumar and Mondal, Sankar Chandra and Rath, Hema and Chawla, Kamaldeep},
title = {Optimising Proton Pump Inhibitor Therapy in Cardiovascular Polypharmacy: Expert Opinion and the Role of Rabeprazole},
journal = {Hypertension Journal},
year = {2025},
volume = {10},
number = {4},
pages = {94--99},
doi = {10.61081/htnj/24v10i403}
}
EUVIMED